Etizolam (marketed under the brand name Etilaam, Etizest, Etizola, Sedekopan, Pasaden or Depas) is a benzodiazepine analog. The etizolam molecule differs from a benzodiazepine in that the benzene ring has been replaced by a thiophene ring, making the drug a thienodiazepine. It possesses amnesic, anxiolytic, anticonvulsant, hypnotic, sedative and skeletal muscle relaxant properties.
Actual product may differ from the image.
・Anxiety disorders associated with depression : 1 mg two to three times a day (maximum 3 mg per day).
・For panic disorder (associated with agoraphobia): 0.5 mg two times per day (maximum 1 mg per day).
・For insomnia: 1–2 mg once daily before bedtime.
A 1 mg dose of etizolam is approximately equivalent to a 10mg dose of diazepam, see List of benzodiazepines.
Blepharospasms with long term use.
Cases of intentional suicide by overdose using etizolam have been reported. Although etizolam has a lower LD50 than certain benzodiazepines, the LD50 is still far beyond the prescribed or recommended dose. Many lethal etizolam overdoses were due to drug interactions.